A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2012

Conditions

Non-Small Cell Lung Cancer (NSCLC)

Interventions

DRUG

PF-00299804

Brief exposure (5- 11 days) to study drug prior to surgical resection

Trial Locations (3)

Pfizer Investigational Site, Birmingham

Pfizer Investigational Site, Los Angeles

Pfizer Investigational Site, Los Angeles